The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Neonatal Respiratory Distress Syndrome Treatment Market Evolve From 2026 To 2030?

The neonatal respiratory distress syndrome treatment market size has seen strong expansion in recent years. It is anticipated to increase from $1.03 billion in 2025 to $1.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.0%. The historical growth trajectory is attributable to elevated premature birth rates, the dependence on conventional oxygen therapy, restricted access to neonatal intensive care units, the initial adoption of natural surfactants, and a rise in infant respiratory morbidity.

The neonatal respiratory distress syndrome treatment market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. This projected growth is driven by several factors, including the creation of sophisticated synthetic surfactants, the broadening of non-invasive ventilation techniques, increasing financial commitment to neonatal care tools, growing worldwide understanding of issues affecting newborns, and the upgrade of hospital-based respiratory support systems. Key trends expected during this period encompass the increased acceptance of surfactant replacement therapies, a rise in the application of CPAP and non-invasive ventilation, improvements in neonatal intensive care facilities, a heightened emphasis on managing premature births, and the ongoing development of both synthetic and bioengineered surfactants.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What Major Drivers Are Influencing Demand In The Neonatal Respiratory Distress Syndrome Treatment Market?

The increasing occurrence of premature births is anticipated to fuel the expansion of the neonatal respiratory distress syndrome treatment market moving forward. Premature births are defined as the delivery of a baby prior to reaching thirty-seven weeks of gestation, leading to incompletely developed organ systems necessitating specialized medical care. A significant element contributing to the surge in premature birth rates is the growing frequency of maternal health issues, given that these conditions can impede typical fetal development and induce early labor due to physiological stress on both the mother and the fetus. Treatment for neonatal respiratory distress syndrome enhances survival rates and provides stability for premature infants whose undeveloped lungs make them very susceptible to respiratory failure. For example, data from September 2024, provided by Statistique Canada, a Canada-based governmental organization, showed that the percentage of births happening before 37 weeks of gestation rose marginally from 8.2% in 2022 to 8.3% in 2023, demonstrating a minor increase in preterm births. Consequently, the growing incidence of premature births is propelling the expansion of the neonatal respiratory distress syndrome treatment market.

Which Segment Areas Are Covered In The Neonatal Respiratory Distress Syndrome Treatment Market Analysis?

The neonatal respiratory distress syndrome treatment market covered in this report is segmented –

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

What Key Trends Are Influencing The Development Of The Neonatal Respiratory Distress Syndrome Treatment Market?

Prominent companies operating in the neonatal respiratory distress syndrome treatment market are concentrating on developing advanced solutions, such as next-generation, mobile nitric-oxide delivery systems. These initiatives aim to enhance oxygenation, reduce treatment complications, and broaden access beyond traditional NICU settings. Portable nitric-oxide systems are medical devices engineered to generate and provide inhaled nitric oxide on demand, thereby improving oxygenation and alleviating pulmonary hypertension in neonates with hypoxic respiratory failure, while also permitting safe application during patient transport. As an illustration, in June 2025, Beyond Air Inc., a US-based medical device company, submitted a PMA supplement to the U.S. Food and Drug Administration for LungFit PH 2. This is a lighter and transport-ready nitric oxide generator that leverages the company’s patented Ionizer technology. Engineered for enhanced portability and user convenience, the device ensures uninterrupted nitric oxide delivery while simultaneously reducing nitrogen dioxide production, thus guaranteeing safer therapy even during neonatal transport. Simultaneously, phase-4 registry data for INOmax, a well-recognized iNO therapy by Mallinckrodt, reveals sustained real-world benefits in neonates affected by pulmonary hypertension, further emphasizing the clinical significance of inhaled nitric oxide in the management of hypoxic respiratory failure in newborns.

Which Global Companies Are Actively Competing In The Neonatal Respiratory Distress Syndrome Treatment Market?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Medtronic Plc, GE Healthcare, Koninklijke Philips NV, Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Windtree Therapeutics Inc., Discovery Laboratories Inc., ResMed Inc., Abbott Laboratories, Aerogen Pharma Corp., ONY Biotech, Yuhan Corporation, Atom Medical Corporation, Mindray Bio-Medical Electronics, Getinge AB, Nihon Kohden Corporation, Siare Engineering Spa

Read the full neonatal respiratory distress syndrome treatment market report here:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Neonatal Respiratory Distress Syndrome Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

Browse Through More Reports Similar to the Global Neonatal Respiratory Distress Syndrome Treatment Market 2026, By The Business Research Company

Neonatal Infant Care Global Market Report

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Light Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Image Guided Radiation Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model